264 related articles for article (PubMed ID: 32668617)
1. Interferon-Induced Transmembrane Protein 1 (IFITM1) Promotes Distant Metastasis of Small Cell Lung Cancer.
Sakamoto S; Inoue H; Kohda Y; Ohba SI; Mizutani T; Kawada M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668617
[TBL] [Abstract][Full Text] [Related]
2. New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice.
Sakamoto S; Inoue H; Ohba S; Kohda Y; Usami I; Masuda T; Kawada M; Nomoto A
Cancer Sci; 2015 Apr; 106(4):367-74. PubMed ID: 25640943
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting of Proliferation, Migration, and Invasion in Lung Cancer Induced by Silencing Interferon-Induced Transmembrane Protein 1 (IFITM1).
Yan J; Jiang Y; Lu J; Wu J; Zhang M
Biomed Res Int; 2019; 2019():9085435. PubMed ID: 31205947
[TBL] [Abstract][Full Text] [Related]
4. Aberrant DNA methylation in the IFITM1 promoter enhances the metastatic phenotype in an intraperitoneal xenograft model of human ovarian cancer.
Kim NH; Sung HY; Choi EN; Lyu D; Choi HJ; Ju W; Ahn JH
Oncol Rep; 2014 May; 31(5):2139-46. PubMed ID: 24676393
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism.
Lee J; Goh SH; Song N; Hwang JA; Nam S; Choi IJ; Shin A; Kim IH; Ju MH; Jeong JS; Lee YS
Am J Pathol; 2012 Jul; 181(1):43-52. PubMed ID: 22609115
[TBL] [Abstract][Full Text] [Related]
6. MGr1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo.
Zhang F; Wang Y; Xu M; Dong H; Liu N; Zhou J; Pang H; Ma N; Zhang N; Pei Y; Zhang H; Liu L
Oncol Rep; 2013 Jun; 29(6):2283-90. PubMed ID: 23588894
[TBL] [Abstract][Full Text] [Related]
7. The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies.
Varker KA; Phelps SH; King MM; Williams CL
Int J Oncol; 2003 Mar; 22(3):671-81. PubMed ID: 12579323
[TBL] [Abstract][Full Text] [Related]
8. KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer.
Simó-Riudalbas L; Pérez-Salvia M; Setien F; Villanueva A; Moutinho C; Martínez-Cardús A; Moran S; Berdasco M; Gomez A; Vidal E; Soler M; Heyn H; Vaquero A; de la Torre C; Barceló-Batllori S; Vidal A; Roz L; Pastorino U; Szakszon K; Borck G; Moura CS; Carneiro F; Zondervan I; Savola S; Iwakawa R; Kohno T; Yokota J; Esteller M
Cancer Res; 2015 Sep; 75(18):3936-45. PubMed ID: 26208904
[TBL] [Abstract][Full Text] [Related]
9. Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer.
Sari IN; Yang YG; Phi LT; Kim H; Baek MJ; Jeong D; Kwon HY
Oncotarget; 2016 Dec; 7(52):86039-86050. PubMed ID: 27852071
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
Wang ZX; Lu BB; Yang JS; Wang KM; De W
J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
[TBL] [Abstract][Full Text] [Related]
11. Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer.
Yang YG; Koh YW; Sari IN; Jun N; Lee S; Phi LTH; Kim KS; Wijaya YT; Lee SH; Baek MJ; Jeong D; Kwon HY
Int J Cancer; 2019 Apr; 144(8):2020-2032. PubMed ID: 30318841
[TBL] [Abstract][Full Text] [Related]
12. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth.
Perurena N; Zandueta C; Martínez-Canarias S; Moreno H; Vicent S; Almeida AS; Guruceaga E; Gomis RR; Santisteban M; Egeblad M; Hermida J; Lecanda F
J Hematol Oncol; 2017 Jan; 10(1):23. PubMed ID: 28103946
[TBL] [Abstract][Full Text] [Related]
13. Combination of IFITM1 knockdown and radiotherapy inhibits the growth of oral cancer.
Yang J; Li L; Xi Y; Sun R; Wang H; Ren Y; Zhao L; Wang X; Li X
Cancer Sci; 2018 Oct; 109(10):3115-3128. PubMed ID: 29770536
[TBL] [Abstract][Full Text] [Related]
14. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
15. Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis.
Aiyama T; Orimo T; Yokoo H; Ohata T; Hatanaka KC; Hatanaka Y; Fukai M; Kamiyama T; Taketomi A
PLoS One; 2020; 15(9):e0239462. PubMed ID: 32956413
[TBL] [Abstract][Full Text] [Related]
16. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional gene expression profiling of small cell lung cancer cells.
Pedersen N; Mortensen S; Sørensen SB; Pedersen MW; Rieneck K; Bovin LF; Poulsen HS
Cancer Res; 2003 Apr; 63(8):1943-53. PubMed ID: 12702587
[TBL] [Abstract][Full Text] [Related]
18. The role and mechanism of IFITM1 in developing acquired cisplatin resistance in small cell lung cancer.
Wang X; Qian H; Yang L; Yan S; Wang H; Li X; Yang D
Heliyon; 2024 May; 10(10):e30806. PubMed ID: 38803858
[TBL] [Abstract][Full Text] [Related]
19. Acquisition and enhanced expression of the metastatic phenotype following transfections of genomic mouse tumor DNA containing human SCLC gene sequences.
Cate CC; Belloni DR; Marin-Padilla M
Clin Exp Metastasis; 1995 May; 13(3):203-17. PubMed ID: 7750208
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of novel orthotopic nude mouse models for human small-cell lung cancer.
Isobe T; Onn A; Morgensztern D; Jacoby JJ; Wu W; Shintani T; Itasaka S; Shibuya K; Koo PJ; O'Reilly MS; Herbst RS
J Thorac Oncol; 2013 Feb; 8(2):140-6. PubMed ID: 23328546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
